Achilles Therapeutics
Achilles Therapeutics is currently undergoing a Members Voluntary (Solvent) Liquidation process as of March 2025. The company has appointed joint liquidators from Teneo Financial Advisory Limited to manage the distribution of its liquidation estate to shareholders and ensure all creditors are paid in full. Its operations are now focused on the legal and financial wind-down of its corporate entities.
Healthtech
Funding summary
- Total raised
- €59.2M
- Funding rounds
- 1
Investors in Achilles Therapeutics
Investors on record for Achilles Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Achilles Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors